SUMO1 and cancer: To test if SUMO1-modified RanGAP1 is also evenly present between the two fractions in other types of cells, we fractionated four cancer cell lines (HeLa, BRL, 293T and U2OS) and two fibroblasts (GM03652 and NIH3T3) for immunoblot analysis.